Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.

"Disclosures Lei Zhang, Diego Novick, Shiying Zhong and Jinnan Li are employees of Eli Lilly and Company and have stocks/shares in Eli Lilly and Company. Chloe Walker, Lewis Harrison, James Jackson, Sophie Barlow, and Sarah Cotton are employees of Adelphi Real World."

"Funding Data collection was undertaken by Adelphi Real World as part of an independent survey, entitled the Adelphi Real World Migraine DSP. Eli Lilly and Company, Indianapolis did not influence the original survey through either contribution to the design of questionnaires or data collection. The analysis described here used data from the Adelphi Real World Migraine DSP. The DSP is a wholly owned Adelphi Real World product. Eli Lilly and Company, Indianapolis is one of multiple subscribers to the DSP. Publication of survey results was not contingent on the subscriber’s approval or censorship of the publication. No funding or sponsorship was received for this study or publication of this article. The Rapid Service Fee was funded by the authors."